메뉴 건너뛰기




Volumn 19, Issue 21, 2011, Pages 6383-6399

Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer

Author keywords

17,20 Lyase; Orteronel; Prostate cancer; TAK 700

Indexed keywords

CYTOCHROME P450 3A4; ORTERONEL; PRASTERONE; STEROID 11BETA MONOOXYGENASE; STEROID 17,20 LYASE; TESTOSTERONE;

EID: 84856780403     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2011.08.066     Document Type: Article
Times cited : (120)

References (68)
  • 1
    • 0000035768 scopus 로고
    • Carcinoma of the prostate
    • J. Y., Crayhack, J. T., Howards, S. S., Duckett, J. W., Eds., 2nd revised ed.; Mosby Year Book Medical Pub: St. Louis, MO, Chapter 34
    • Kozlowski.J. M.; Crayhack.J. T. Carcinoma of the prostate. In Adult and Pediatric Urology; Cillenwater, J. Y., Crayhack, J. T., Howards, S. S., Duckett, J. W., Eds., 2nd revised ed.; Mosby Year Book Medical Pub: St. Louis, MO, 1991. Chapter 34.
    • (1991) Adult and pediatric urology; Cillenwater
    • Kozlowski, J.M.1    Crayhack, J.T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.